← All indications
Community-Acquired Infections
Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.
Subtype terms (1)
More specific conditions that are subtypes of Community-Acquired Infections in the MeSH hierarchy.
Drugs by status
Approved for this indication (3)
Phase 4 trials (28)
- simvastatin
- levofloxacin
- metronidazole
- methylprednisolone
- ceftaroline fosamil
- ambroxol
- astaxanthin
- urea
- procaine benzylpenicillin
- clavulanate
- doxycycline
- hydrocortisone
- amoxicillin
- ceftriaxone
- telithromycin
- ciprofloxacin
- azithromycin
- varenicline
- clarithromycin
- cefuroxime
- moxifloxacin
- phenoxymethylpenicillin
- cephalexin
- sodium chloride
- minocycline
- oxacillin
- Andrographis paniculata
- nemonoxacin
Phase 3 trials (28)
- heparin
- cefazolin
- ceftazidime
- ceftobiprole
- solithromycin
- delafloxacin
- prednisone
- betamethasone
- doripenem
- faropenem medoxomil
- aciclovir
- ginseng
- albumin (Human)
- icosapent ethyl
- tigecycline
- lefamulin
- omadacycline
- shenfu
- dalbavancin
- ophiochepalus striatus extract
- qingfeijieduhuatan
- zaoshihuatanxiefei
- qingxinkaiqiao
- cefepime
- ertapenem
- fructus schizandrae
- IgM Concentrate
- rafamin
Phase 2 trials (18)
Phase 1 trials (4)
Organizations
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (2)